MedTrace Logo

Danger Response in Polytrauma Patients

NCT02682550 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2016-02-15

No results posted yet for this study

Summary

The NTF\_PT\_2014 multicenter study aims to collect, store, and analyse plasma and serum from polytrauma-patients (injury severity score ≥25) and corresponding clinical data to address 1) how trauma modulates the release of danger molecules, inflammatory mediators, coagulation factors and novel biomarkers, 2) how the specific injury pattern affects the posttraumatic response and regenerative potential on an organ-, cell, and molecular level, and 3) how could a specific organ- and immune-monitoring predict the clinical outcome.

Conditions

  • Multiple Trauma

Interventions

PROCEDURE

blood drawing

blood drawing

Sponsors & Collaborators

  • University of Ulm

    lead OTHER

Principal Investigators

  • Markus Huber-Lang, M.D. Prof · University of Ulm, Center for Biomedical Research (ZBF)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2018-09-30
Completion
2018-10-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02682550 on ClinicalTrials.gov